Robert R. Gorman

5.9k citations

90 papers · 4.8k indexed · 2 hit papers · h-index 37

Impact in

Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology
Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects

Papers in

Pharmacology 50
- Inflammatory mediators and NSAID effects 44
- Pharmacology and Obesity Treatment 7
Biochemistry 21
- Eicosanoids and Hypertension Pharmacology 20

Co-authors: O.V. Miller Edward J. Goetzl S Bunting Nancy K. Hopkins Alice H. Lin Roy A. Johnson James W. Aiken Douglas R. Morton
Journals: Prostaglandins (21 papers)Biochemical and Biophysical Research Communications (9 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of Clinical Investigation (4 papers)Journal of Biological Chemistry (4 papers)
Partner nations: United States Sweden South Korea

In The Last Decade

Robert R. Gorman

89 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Modulation of human platelet adenylate cyclase by prostacyclin (PGX) 1977 · 538 citations

Peers

Countries citing papers authored by Robert R. Gorman

Since Specialization

Citations

This map shows the geographic impact of Robert R. Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Gorman more than expected).

Fields of papers citing papers by Robert R. Gorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Gorman. The network helps show where Robert R. Gorman may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert R. Gorman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert R. Gorman Line = papers co-authored together Robert R. Gorman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Troeger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity Journal of Medicinal Chemistry ·Richard Johnson, Robert R. Gorman, Richard J. Wnuk, N.J. Crittenden, James W. Aiken	1993	54
2	2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity. Journal of Pharmacology and Experimental Therapeutics ·C W Benjamin, Alice H. Lin, Jenny Morris, Donn G. Wishka, Robert R. Gorman	1993	11
3	Activation of Human Eosinophils by Platelet-Derived Growth Factor International Archives of Allergy and Immunology ·Michael K. Bach, John R. Brashler, Barbara K. Stout, Herbert G. Johnson, Martin E. Sanders, Alice H. Lin, Robert R. Gorman, Michael J. Bienkowski, Teruko Ishizaka	1992	20
4	Thromboxane Synthase Activity and Platelet Function After Furegrelate Administration in Man The Journal of Clinical Pharmacology ·J. Scott Mohrland, J. T. Vander Lugt, Robert R. Gorman, Duane B. Lakings	1989	11
5	Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene American Journal of Physiology-Cell Physiology ·N. E. Owen, Jacquelyn A. Knapik, F. R. Strebel, W. Gary Tarpley, Robert R. Gorman	1989	7
6	NIH-3T3 cells expressing high levels of the c- ras proto-oncogene display reduced platelet derived growth factor-stimulated phospholipase activity Biochemical and Biophysical Research Communications ·P. L. Olinger, Robert R. Gorman	1988	5
7	NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization. Proceedings of the National Academy of Sciences ·C W Benjamin, John A. Connor, W. Gary Tarpley, Robert R. Gorman	1988	48
8	Modular transport ventilation system for twins Critical Care Medicine ·Teertharaj K. Belgaumkar, NORMAN B. PATRICK, Robert R. Gorman	1987	2
9	Inhibition of platelet function in thrombosis. Circulation ·Aaron J. Marcus, L B Safier, H L Ullman, M. Johan Broekman, N Islam, Thomas D. Oglesby, Robert R. Gorman, J W Ward	1985	14
10	The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Thomas D. Oglesby, Robert R. Gorman	1984	27
11	Leukotriene B4 binding to human neutrophils Prostaglandins ·Alice H. Lin, Patricia L. Ruppel, Robert R. Gorman	1984	75
12	12S,20-dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. Proceedings of the National Academy of Sciences ·Aaron J. Marcus, L B Safier, H L Ullman, M. Johan Broekman, N Islam, Thomas D. Oglesby, Robert R. Gorman	1984	115
13	Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate Prostaglandins ·Robert R. Gorman, Roy A. Johnson, C.H. Spilman, James W. Aiken	1983	61
14	Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·O.V. Miller, Donald E. Ayer, Robert R. Gorman	1982	21
15	Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis. Journal of Pharmacology and Experimental Therapeutics ·James W. Aiken, Ronald J. Shebuski, O.V. Miller, Robert R. Gorman	1981	103
16	An antiserum against 9,11-azo-15-hydroxy-prosta-5,13-dienoic acid recognises and binds prostaglandin endoperoxides Nature ·F.A. Fitzpatrick, Robert R. Gorman, Gordon L. Bundy	1978	6
17	The effect of PGH2 on blood flow in the canine renal and superior mesenteric vascular beds Prostaglandins ·Larry P. Feigen, B. M. Chapnick, Robert R. Gorman, Albert L. Hyman, Philip J. Kadowitz	1978	0
18	A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2 Biochemical and Biophysical Research Communications ·Robert R. Gorman, F.A. Fitzpatrick, O.V. Miller	1977	15
19	A radioimmunoassay for thromboxane B2 Analytical Biochemistry ·F.A. Fitzpatrick, Robert R. Gorman, J.C. Mc Guire, Robert C. Kelly, Michael A. Wynalda, F.F. Sun	1977	121
20	Epinephrine binding and the selective restoration of adenylate cyclase activity in fat-fed rats Journal of Lipid Research ·Robert R. Gorman, Helen M. Tepperman, Jay Tepperman	1973	33

About Robert R. Gorman

Robert R. Gorman is a scholar working on Pharmacology, Biochemistry, Cardiology and Cardiovascular Medicine, Physiology and Analytical Chemistry, having authored 90 papers that have together received 4.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (44 papers), Antiplatelet Therapy and Cardiovascular Diseases (22 papers), Eicosanoids and Hypertension Pharmacology (20 papers), Nitric Oxide and Endothelin Effects (13 papers), Asthma and respiratory diseases (10 papers), Pharmacology and Obesity Treatment (7 papers), Receptor Mechanisms and Signaling (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). The work is most often cited by research in Biochemistry (1.1k citations), Pharmacology (2.0k citations), Cardiology and Cardiovascular Medicine (945 citations), Physiology (1.1k citations) and Internal Medicine (123 citations). Robert R. Gorman has collaborated with scholars based in United States, Sweden and South Korea. Frequent co-authors include O.V. Miller, Edward J. Goetzl, S Bunting, Nancy K. Hopkins, Alice H. Lin, Roy A. Johnson, James W. Aiken, Douglas R. Morton, Ronald J. Shebuski and Gordon L. Bundy. Their work appears in journals such as Prostaglandins, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact